Perspective Therapeutics, Inc. (CATX) Financials

CATX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 410.8 million 63.3 million
Dec. 31, 2025 267.0 million 59.9 million
Sept. 30, 2025 294.8 million 52.6 million
June 30, 2025 310.7 million 45.0 million

CATX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -38.3 million 2.6 million
Dec. 31, 2025 -29.7 million 2.3 million
Sept. 30, 2025 -18.3 million 2.2 million
June 30, 2025 -21.0 million 2.4 million

CATX Net Income

No data available :(

CATX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 270.9 million 1.6 million -
Dec. 31, 2025 144.7 million 1.0 million 1.6 million
Sept. 30, 2025 174.1 million 1.6 million 1.7 million
June 30, 2025 191.6 million 1.6 million 1.9 million

CATX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 103.6 million
Dec. 31, 2025 73.8 million
Sept. 30, 2025 74.3 million
June 30, 2025 70.7 million

CATX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 6.9 million 20.2 million 7.0 million -
Dec. 31, 2025 5.1 million 32.9 million 7.0 million -
Sept. 30, 2025 2.0 million 20.3 million 7.7 million -
June 30, 2025 1.0 million 12.2 million 7.7 million -

CATX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 76000 1.1 million
Dec. 31, 2025 43000 1.0 million
Sept. 30, 2025 209000 775000
June 30, 2025 290000 733000

CATX

Price: $2.91

52 week price:
1.96
6.16

Earnings Per Share: -1.41 USD

Exchange: ASE

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 278.9 million

Links: